Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

University of Texas at Austin

United States
2 Trials1 Paper

The Center for Psychedelic Research and Therapy within the Dell Medical School conducts clinical research with various psychedelics, including psilocybin, MDMA, ibogaine, and ayahuasca. A major and unique focus of the center at UTA is its dedication to using psychedelics to treat military veterans suffering from PTSD, as well as adults experiencing prolonged grief disorder and those who have survived childhood trauma.

Academic Research

1 papers

Published Papers

1

Trial Involvement

2

Distinct Focus Topics

0

Latest Publication

Oct 1, 2024

Quick Facts

Type
academic
HQ
United States
Website
Visit

Sponsored Trials

1
RecruitingII

Psilocybin rTMS for Treatment Resistant Depression

Start Date
Compounds
Psilocybin

Collaborated Trials

1
CompletedII

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

Start Date
Compounds
Ketamine, Placebo

Research Papers

1
Paywallindividual

Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity

This re-analysis of an RCT study (n=20) tested the acute effects of psilocybin and 2C-B on the encoding of emotional episodic memories. The study finds that both psychedelics impair estimates of recollection and familiarity, increase familiarity-based false alarms for emotional stimuli, and affect metamemory, indicating a common neurocognitive mechanism across these drugs.

Published
Journal
Biological Psychiatry
Authors
Doss, M. K., Mallaroni, P., Mason, N. L., Ramaekers, J. G.